Early research (Phase 1)Study completedNCT01570244What this trial is testingDrug-drug Interaction of BI 201335 and MicrogynonWho this might be right forHepatitis C, Chronic Boehringer Ingelheim 16
Large-scale testing (Phase 3)Study completedNCT01854528What this trial is testingEvaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) for Treatment of Chronic Hepatitis C Infection in Treatment-experienced AdultsWho this might be right forChronic Hepatitis C Infection AbbVie 148
Not applicableUnknownNCT06373198What this trial is testingImplementation of a Re-engagement Program for Hepatitis C Patients Lost to Follow-up in Argentina.Who this might be right forHepatitis C ChronicHepatitis C Hospital El Cruce 800
Not applicableStudy completedNCT00728494What this trial is testingCompliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671)Who this might be right forHepatitis C, ChronicHepatitis C Merck Sharp & Dohme LLC 99
Not applicableStudy completedNCT00512941What this trial is testingLaboratory Profile of Hepatitis B and C in Users of a Reference ServiceWho this might be right forHepatitis, Viral, Non-A, Non-B, Parenterally-TransmittedHepatitis B, Chronic UPECLIN HC FM Botucatu Unesp 531
Not applicableStudy completedNCT05062408What this trial is testingImpact of the Sustained Viral Response of Chronic Hepatitis c After Treatment With Direct Action AntiviralsWho this might be right forHepatitis C, Chronic Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 321
Large-scale testing (Phase 3)Study completedNCT04387526What this trial is testingSofosbuvir Plus Daclatasvir With or Without Ribavirin and Chronic HCV Genotype (GT) 4Who this might be right forChronic Hepatitis C Virus Infection Beni-Suef University 946
Testing effectiveness (Phase 2)Ended earlyNCT00229749What this trial is testingStudy of AVI-4065 in Healthy Volunteers and Chronic Active HCV PatientsWho this might be right forHepatitis C Sarepta Therapeutics, Inc. 80
Not applicableUnknownNCT00160940What this trial is testingDifferential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral HepatitisWho this might be right forHepatitis CHepatitis BAutoimmune Hepatitis+2 more University Health Network, Toronto 200
Large-scale testing (Phase 3)Study completedNCT03578640What this trial is testingEight Weeks of Elbasvir/Grazoprevir in the Treatment of HCV Genotype 4Who this might be right forHepatitis C, Chronic King Fahad Medical City 30
Not applicableStudy completedNCT05067374What this trial is testingHepatitis C Screening Paired With MammographyWho this might be right forHepatitis CBreast Cancer University Hospital, Montpellier 1,500
Testing effectiveness (Phase 2)Study completedNCT04246723What this trial is testingEfficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Sofosbuvir in Treatment-naïve Patients With Chronic Hepatitis C Genotype 1Who this might be right forChronic Hepatitis c Genotype 1 R-Pharm 85
Testing effectiveness (Phase 2)WithdrawnNCT00895882What this trial is testingStudy to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN)Who this might be right forChronic Genotype 1 Hepatitis C Virus Infection Merck Sharp & Dohme LLC
Post-approval studies (Phase 4)Study completedNCT00087594What this trial is testingPEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program.Who this might be right forHepatitis C, Chronic Hoffmann-La Roche 48
Post-approval studies (Phase 4)Study completedNCT02786537What this trial is testingStudy of Oral Treatments for Hepatitis CWho this might be right forChronic Hepatitis C University of Florida 1,275
Large-scale testing (Phase 3)Study completedNCT01389323What this trial is testingBMS-790052 (Daclatasvir) Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis CWho this might be right forHepatitis C Bristol-Myers Squibb 448
Testing effectiveness (Phase 2)UnknownNCT01024894What this trial is testingDose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in Asiatic HCV Patients Resistant to BitherapyWho this might be right forHepatitis C Cytheris SA 15
Large-scale testing (Phase 3)UnknownNCT01664845What this trial is testingEffects of Metformin, Pegylated Interferon Alpha and Ribavirin for Chronic Hepatitis C With Insulin ResistanceWho this might be right forChronic Hepatitis cInsulin Resistance Kaohsiung Veterans General Hospital. 120
Testing effectiveness (Phase 2)Study completedNCT00606086What this trial is testingSafety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C InfectionWho this might be right forGenotype 1 Chronic Hepatitis C GlobeImmune 140
Post-approval studies (Phase 4)Study completedNCT00001854What this trial is testingLong-Term Therapy With Ribavirin for Chronic Hepatitis CWho this might be right forChronic Hepatitis C National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 50